4 completed, 1 unknown. 5 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 5 | Completed 4, Unknown 1 |
Follow Natesto: new trials by email Literature Review of Natesto trials Research Report on Natesto
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Monitor Ambulatory Blood Pressure Monitoring in Hypogonadal Men Treated With Nasal Testosterone Gel Natesto - Hypogonadism | Phase 4 | Unknown | Acerus Pharmaceuticals Corporation | 218 | 2021-07-01 | 2022-07-06 |
| A Comparison of Side Effects in Hypogonadal Men Treated With Natesto Versus Testosterone Injections Testosterone Cypionate 200 Mg/ML, Intranasal Testosterone - Hypogonadism, Male | Phase 4 | Completed | University of Miami | 81 | 2020-08-07 | 2023-12-13 |
| Natesto Effects on Testosterone, Luteinizing Hormone, Follicle Stimulating Hormone and Semen Parameters Natesto - Hypogonadism, Male | Phase 4 | Completed | University of Miami | 60 | 2017-10-27 | 2021-10-19 |
| Open-Label Study, Evaluating Patient Satisfaction and Symptom Improvement When Treating Male Hypogonadism With Natesto™ NATESTO Testosterone Nasal Gel - Hypogonadism | Phase 4 | Completed | Acerus Pharmaceuticals Corporation | 117 | 2016-10-01 | 2019-08-12 |
| Intranasal Delivery of Testosterone and Its Effect on Doping Markers Testosterone - Abuse of Anabolic Steroids | Phase 4 | Completed | University of Utah | 5 | 2015-11-18 | 2020-02-11 |
Eunuchism (2) · Hypogonadism (2) · Endocrine System Diseases (1) · Gonadal Disorders (1)
Acerus Pharmaceuticals Corporation (2) · University of Miami (2) · University of Utah (1)
United States (4) · Canada (1)
Ranjith Ramasamy, MD (2) · Nathan Bryson, Ph.D. (1) · Stuart Willick, MD (1)